Cycle Pharmaceuticals and Handa Therapeutics Forge Strategic Partnership to Launch PHYRAGO for Leukemia Patients in the U.S.
In a major stride towards revolutionizing leukemia treatment in the U.S., Cycle Pharmaceuticals has signed an exclusive sales license agreement […]









